Leming Shi

Leming Shi

Auto-generated profile, based on publicly available information

Leming Shi

Fudan University, China

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2019 in Cancer Cell
Verified
Journal Article
Closed access
YJYi-Zhou Jiang
Yi-Zhou Jiang
DMDing Ma
Ding Ma
CSChen Suo
Chen Suo
JSJinxiu Shi
Jinxiu Shi
MXMengzhu Xue
Mengzhu Xue
ZSZhi-Ming Shao
Zhi-Ming Shao

25 June 2015 in Genome Biology
Verified
Journal Article
Open access
PDF file
WZWenqian Zhang
Wenqian Zhang
YYYing Yu
Ying Yu
FHFalk Hertwig
Falk Hertwig
JTJean Thierry-Mieg
Jean Thierry-Mieg
WZWenwei Zhang
Wenwei Zhang
MFMatthias Fischer
Matthias Fischer
Background: Gene expression profiling is being widely applied in cancer research to identify biomarkers for clinical endpoint prediction. Since RNA-seq provides a powerful tool for transcriptome-based applications beyond the limitations of microarrays, we sought to systematically evaluate the performance of RNA-seq-based and microarray-based classifiers in this MAQC-III/SEQC study for clinical endpoint prediction using neuroblastoma as a model. Results: We generate gene expression profiles from 498 primary neuroblastomas using both RNA-seq and 44 k microarrays. Characterization of the neuroblastoma transcriptome by RNA-seq reveals that more than 48,000 genes and 200,000 transcripts are being expressed in this malignancy. We also find that RNA-seq provides much more detailed information on specific transcript expression patterns in clinico-genetic neuroblastoma subgroups than microarrays. To systematically compare the power of RNA-seq and microarray-based models in predicting clinical endpoints, we divide the cohort randomly into training and validation sets and develop 360 predictive models on six clinical endpoints of varying predictability. Evaluation of factors potentially affecting model performances reveals that prediction accuracies are most strongly influenced by the nature of the clinical endpoint, whereas technological platforms (RNA-seq vs. microarrays), RNA-seq data analysis pipelines, and feature levels (gene vs. transcript vs. exon-junction level) do not significantly affect performances of the models. Conclusions: We demonstrate that RNA-seq outperforms microarrays in determining the transcriptomic characteristics of cancer, while RNA-seq and microarray-based models perform similarly in clinical endpoint prediction. Our findings may be valuable to guide future studies on the development of gene expression-based predictive models and their implementation in clinical practice.

3 October 2024 in Genome Biology
Verified
Journal Article
Open access
PDF file
YYYing Yu
Ying Yu
YMYuanbang Mai
Yuanbang Mai
YZYuanting Zheng
Yuanting Zheng
LSLeming Shi
Leming Shi
Batch effects in omics data are notoriously common technical variations unrelated to study objectives, and may result in misleading outcomes if uncorrected, or hinder biomedical discovery if over-corrected. Assessing and mitigating batch effects is crucial for ensuring the reliability and reproducibility of omics data and minimizing the impact of technical variations on biological interpretation. In this review, we highlight the profound negative impact of batch effects and the urgent need to address this challenging problem in large-scale omics studies. We summarize potential sources of batch effects, current progress in evaluating and correcting them, and consortium efforts aiming to tackle them.

23 June 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
BLBin Li
Bin Li
TQTao Qing
Tao Qing
JZJinhang Zhu
Jinhang Zhu
ZWZhuo Wen
Zhuo Wen
YYYing Yu
Ying Yu
LSLeming Shi
Leming Shi
The mouse has been widely used as a model organism for studying human diseases and for evaluating drug safety and efficacy. Many diseases and drug effects exhibit tissue specificity that may be reflected by tissue-specific gene-expression profiles. Here we construct a comprehensive mouse transcriptomic BodyMap across 17 tissues of six-weeks old C57BL/6JJcl mice using RNA-seq. We find different expression patterns between protein-coding and non-coding genes. Liver expressed the least complex transcriptomes, that is, the smallest number of genes detected in liver across all 17 tissues, whereas testis and ovary harbor more complex transcriptomes than other tissues. We report a comprehensive list of tissue-specific genes across 17 tissues, along with a list of 4,781 housekeeping genes in mouse. In addition, we propose a list of 27 consistently and highly expressed genes that can be used as reference controls in expression-profiling analysis. Our study provides a unique resource of mouse gene-expression profiles, which is helpful for further biomedical research.

9 September 2021 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
WXWenming Xiao
Wenming Xiao
LRLuyao Ren
Luyao Ren
ZCZhong Chen
Zhong Chen
LFLi Tai Fang
Li Tai Fang
YZYongmei Zhao
Yongmei Zhao
LSLeming Shi
Leming Shi

7 September 2023 in Nature Biotechnology
Verified
Journal Article
Open access
PDF file
YZYuanting Zheng
Yuanting Zheng
YLYaqing Liu
Yaqing Liu
JYJingcheng Yang
Jingcheng Yang
LDLianhua Dong
Lianhua Dong
RZRui Zhang
Rui Zhang
LSLeming Shi
Leming Shi
Characterization and integration of the genome, epigenome, transcriptome, proteome and metabolome of different datasets is difficult owing to a lack of ground truth. Here we develop and characterize suites of publicly available multi-omics reference materials of matched DNA, RNA, protein and metabolites derived from immortalized cell lines from a family quartet of parents and monozygotic twin daughters. These references provide built-in truth defined by relationships among the family members and the information flow from DNA to RNA to protein. We demonstrate how using a ratio-based profiling approach that scales the absolute feature values of a study sample relative to those of a concurrently measured common reference sample produces reproducible and comparable data suitable for integration across batches, labs, platforms and omics types. Our study identifies reference-free ‘absolute’ feature quantification as the root cause of irreproducibility in multi-omics measurement and data integration and establishes the advantages of ratio-based multi-omics profiling with common reference materials.